Stock SOPH SOPHIA GENETICS SA
Add to a list
To use this feature you must be a member
Log inSign up

Consensus SOPHiA GENETICS SA

Equities

SOPH

CH1125843347

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
4.8 USD -1.03% Intraday chart for SOPHiA GENETICS SA -4.00% +1.91%
Apr. 17 SOPHiA GENETICS Announces Unilabs Using Its AI Technology to Detect Homologous Recombination Deficiency CI
Apr. 04 Sophia Genetics Forms Partnership With Strand Life Sciences to Advance Diagnostic Tools MT

Evolution of the average Target Price on SOPHiA GENETICS SA

Price target over the last 5 years

History of analyst recommendation changes

420d6a2d352546c7afd3d398c.uApVOEvI2j5cqHH6KmBgH8IL6SyeFS5ZJO9wH87vX6o.gU8nSH-LvA1ozhyWfg5SVoxov2fPTBoeHKgKK6CAN8GOeTxnCZi7ahvaSQ~17fbea1be65efb733a9d617dadb21112

Analyst Recommendations on SOPHiA GENETICS SA

RBC Initiates SOPHiA GENETICS at Outperform With $8 Price Target, Notes 'Attractive' Entry Point, Exposure to Long-Term Growth in Sequencing, Life Science Research MT
Credit Suisse Raises SOPHiA GENETICS' Price Target to $5 From $2.25 After 'Solid' Q1 Results, Keeps Neutral Rating MT
Morgan Stanley Trims Price Target on Sophia Genetics to $10 From $11, Maintains Overweight Rating MT
Morgan Stanley Adjusts Price Target on SOPHiA GENETICS to $11 From $12, Maintains Overweight Rating MT
BTIG Starts SOPHiA GENETICS at Buy With $6 Price Target MT
Credit Suisse Starts SOPHiA GENETICS at Neutral With $2 Price Target MT
Morgan Stanley Adjusts Price Target on SOPHiA GENETICS to $12 From $13, Maintains Overweight Rating MT
JPMorgan Lowers Price Target for SOPHiA GENETICS SA to $18 From $23, Maintains Overweight Rating MT
Morgan Stanley Adjusts SOPHiA GENETICS' Price Target to $17 from $18, Keeps Overweight Rating MT
Morgan Stanley Adjusts SOPHiA GENETICS Price Target to $18 From $23, Maintains Overweight Rating MT
SOPHIA GENETICS : Credit Suisse Starts SOPHiA GENETICS at Outperform with $22 Price Target MT
SOPHIA GENETICS : Morgan Stanley Starts SOPHiA GENETICS at Overweight With $24 Price Target MT
SOPHIA GENETICS : JPMorgan Starts SOPHiA GENETICS at Overweight With $23 Price Target MT
SOPHIA GENETICS : Cowen Initiates Coverage on SOPHiA GENETICS SA With Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.8 USD
Average target price
8.667 USD
Spread / Average Target
+80.56%
High Price Target
10 USD
Spread / Highest target
+108.33%
Low Price Target
8 USD
Spread / Lowest Target
+66.67%

Consensus detail

Consensus revision (last 18 months)

Analysts covering SOPHiA GENETICS SA

RBC Capital Markets
Morgan Stanley
Credit Suisse
BTIG
JPMorgan Chase
Cowen

Ratings for SOPHiA GENETICS SA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SOPH Stock
  4. Consensus SOPHiA GENETICS SA